Verisign Inc/ca Form 4 insider transactions
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP and CFO, John Calys, reported the disposition of common stock to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, disposed of common stock valued at $252.88 per share to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 9,900 shares of common stock for approximately $2.47 million between November 11 and November 13, 2025, as part of a pre-arranged 10b5-1 trading plan.
NASDAQ
VRSN
Verisign Inc/caA VeriSign executive sold 668 shares of common stock in pre-planned transactions, reducing beneficial ownership.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP and Chief Financial Officer, John Calys, reported the sale of 1,001 shares of common stock for approximately $242,954, executed under a Rule 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caA VeriSign executive sold 334 shares of common stock for $244.52 per share, reducing their direct beneficial ownership to 33,855.2718 shares.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP of Technology & CSO, Danny R. McPherson, sold 2,500 shares of common stock for approximately $592,175 under a pre-arranged Rule 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 8,900 shares of common stock over three days in October 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 9,000 shares of common stock over three days in October 2025, pursuant to a Rule 10b5-1 trading plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP of Technology & CSO, Danny R. McPherson, disposed of 26.3361 shares of common stock to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, reported the sale of 501 shares of common stock for $262.92 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for $270.87 per share under a pre-arranged trading plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign Director Matthew J. Desch received an award of 728 restricted stock units, which vested immediately upon grant.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 2,000 shares of common stock through a Rule 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold a total of 7,000 shares of common stock in multiple transactions on September 16 and 17, 2025, under a Rule 10b5-1 trading plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold a total of 8,750 shares of common stock over several transactions in early September 2025 under a Rule 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for $282.28 per share under a pre-arranged 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for $270.46 per share under a pre-arranged 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 9,000 shares of common stock for approximately $2.4 million over three days in August 2025, pursuant to a Rule 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign Director Timothy Tomlinson reported the sale of 700 shares of common stock at $270 per share, executed under a pre-arranged 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP and CFO, John Calys, disposed of shares to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VRSN
Verisign Inc/caA VeriSign executive disposed of common stock shares to cover tax liabilities related to the vesting of restricted stock units.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP of Technology and CSO, Danny R. McPherson, disposed of shares valued at approximately $168,121 to cover tax liabilities from restricted stock unit vesting.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, reported the disposition of shares to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VRSN
Verisign Inc/caVeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 9,000 shares of common stock for approximately $2.34 million through a pre-arranged 10b5-1 plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for $264.5 per share as part of a pre-arranged trading plan.
NASDAQ
VRSN
Verisign Inc/caVeriSign's EVP, General Counsel, and Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for approximately $135,000 under a Rule 10b5-1 trading plan.
NASDAQ
VRSN
Verisign Inc/caBerkshire Hathaway Inc. and Warren E. Buffett reported the sale of 4.3 million shares of VeriSign Inc. common stock for approximately $1.21 billion, effective July 30, 2025.
NASDAQ
VRSN
Verisign Inc/caVeriSign Inc. Director Debra McCann received an award of 879 restricted stock units, which vested immediately upon grant on July 21, 2025.
NASDAQ
VRSN
Verisign Inc/caVeriSign Director Courtney D. Armstrong received an award of 879 restricted stock units, vesting immediately on July 21, 2025.